Medtronic plc (NYSE:MDT) headquartered in Dublin, will host a conference call for the investment community to discuss the 2Q21 earnings result on 24th November 2020 at 8:00 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.medtronic.com
Earnings Expectation
Medtronic plc manufacturer of medical therapy devices, is expected to report second quarter earnings results, before market open, on Tuesday 24th November 2020. Analysts polled by Thomson Reuters anticipate second quarter income of $ 0.80 per share from revenue of $ 7081.21 million. Looking ahead, the full year income are expected at $ 4.01 per share on the revenues of $ 29206.50 million.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates in four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software.
